Berlin-Brandenburg Pregnancy Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorCharite University, Berlin, Germany
About this trial
This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
healthy pregnant women after giving informed consent
pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes
Disqualifiers
infections
alcohol and drug abuse
manifest and chronic diseases
Trial population
Pregnant women between 18 and 45 years of age without infections, severe or chronic diseases
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
T cell population content at the time of preeclampsia diagnosis compared to controls and verified by flow cytometry
Time frame
at the time of preeclampsia diagnosis compared to controls at the same time point in pregnancySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov